Inventor
MIYAZAKI TOHRU
JP23 patents
⚠️ This page may combine multiple inventors who share the name “MIYAZAKI TOHRU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAKEDA PHARMACEUTICALS CO
14 patentsUS10584097B2Mar 10, 2020
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO14 citations94
US10428023B2Oct 1, 2019
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO22 citations94
US11028048B2Jun 8, 2021
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO8 citations82
US11440883B2Sep 13, 2022
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO3 citations73
US11655241B2May 23, 2023
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO2 citations72
US11319286B2May 3, 2022
Heterocyclic compound and application thereof
TAKEDA PHARMACEUTICALS CO4 citations72
US10435399B2Oct 8, 2019
HDAC6 inhibitory heterocyclic compound
TAKEDA PHARMACEUTICALS CO5 citations71
US12421188B2Sep 23, 2025
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO0 citations62
US12415782B2Sep 16, 2025
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO0 citations62
US12404237B2Sep 2, 2025
Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives
TAKEDA PHARMACEUTICALS CO0 citations62
US12077522B2Sep 3, 2024
Heterocyclic compound and application thereof
TAKEDA PHARMACEUTICALS CO0 citations51
US12091410B2Sep 17, 2024
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations50
US12071434B2Aug 27, 2024
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations50
US12084436B2Sep 10, 2024
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations49
ONO PHARMACEUTICAL CO
6 patentsUS6376484B1Apr 23, 2002
Tetrazole compounds and pharmaceutical agents containing such derivative as an active ingredient
ONO PHARMACEUTICAL CO25 citations92
US6136834AOct 24, 2000
Tetrazole compounds and pharmaceutical agents containing such derivative
ONO PHARMACEUTICAL CO41 citations92
US6177466B1Jan 23, 2001
Sulfonylamino acid derivatives
ONO PHARMACEUTICAL CO18 citations89
US5168101ADec 1, 1992
Sulfonamide derivatives
ONO PHARMACEUTICAL CO14 citations74
US6022893AFeb 8, 2000
Hydroxamic acid derivatives
ONO PHARMACEUTICAL CO14 citations70
US6403644B1Jun 11, 2002
Method of treating disease with sulfonylamino acid derivatives
ONO PHARMACEUTICAL CO2 citations59